Stock Information

• Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
  Thu, Aug 13, 2026 11:03 PM
• Viatris (VTRS) Q2 2026 Earnings Call Transcript
  Thu, Aug 13, 2026 6:13 PM
• Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio: Q2 2026 Update
  Wed, Aug 12, 2026 7:47 PM
• Is AMRX Stock a Buy as Growth Improves but Execution Risks Persist?
  Wed, Aug 12, 2026 3:51 PM
• TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks
  Tue, Aug 11, 2026 1:30 PM
• VTRS Q2 Deep Dive: China Growth, Pipeline Progress, and Margin Concerns Shape Outlook
  Tue, Aug 11, 2026 8:53 AM
• Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program
  Mon, Aug 10, 2026 1:14 AM
• Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval
  Sun, Aug 9, 2026 8:10 PM
• Viatris (VTRS) Raises 2026 Guidance, Is The 11% Gap Below Fair Value Enough?
  Sun, Aug 9, 2026 2:10 PM
• Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress
  Sun, Aug 9, 2026 9:11 AM

Financial data not available